Literature DB >> 3887627

Renal autotransplantation versus bypass techniques for renovascular hypertension.

J M Dubernard, X Martin, A Gelet, D Mongin, F Canton, A Tabib.   

Abstract

From 1972 to 1983, 78 patients underwent surgical treatment for renovascular hypertension caused by a lesion limited to the trunk of the renal artery. Forty-five of these patients underwent aortorenal bypass (24 saphenous grafts and 21 arterial hypogastric grafts); 36 patients (80%) had either a relief of the hypertension or were improved. Graft closure occurred in five cases. Thirty-three patients were treated by autotransplantation of the kidney. After resection of the lesion, the renal artery was anastomosed end-to-end to the hypogastric artery or end-to-side to the common iliac artery and the renal vein and side-to-side to the iliac vein or the origin of the vena cava. In this group all patients but one (97%) had relief of the hypertension or were improved. No thrombosis was observed. Late angiography was performed 5 years after surgery in 19 patients (nine autotransplantations and 10 bypass operations): patients who underwent autotransplantation had no alteration of the renal vessels whereas four patients who underwent bypass operations had dilatation of the saphenous vein bypass. Renal autotransplantation was superior to the bypass technique in the surgical treatment of renovascular hypertension caused by lesions of the trunk of the renal artery and may represent a better alternative in the surgical treatment of this condition.

Entities:  

Mesh:

Year:  1985        PMID: 3887627

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  10 in total

1.  Renovascular hypertension treated by renal autotransplantation.

Authors:  D R Singh; S N Sagade
Journal:  Indian J Pediatr       Date:  2000-06       Impact factor: 1.967

2.  Future aspects of renal transplantation.

Authors:  L Makowka; W B Lopatin; R Shapiro; A G Tzakis; T E Starzl
Journal:  World J Urol       Date:  1988-08       Impact factor: 4.226

3.  [Transluminal dilatation and other nonsurgical catheter technics in the treatment of renovascular hypertension].

Authors:  P Grützmacher; W D Bussmann
Journal:  Klin Wochenschr       Date:  1986-09-15

Review 4.  Kidney Autotransplantation: Between the Past and the Future.

Authors:  Mahmoud Alameddine; Zhobin Moghadamyeghaneh; Ali Yusufali; Alexa Marie Collazo; Joshua S Jue; Ian Zheng; Mahmoud Morsi; Nachiketh Soodana Prakash; Javier Gonzalez
Journal:  Curr Urol Rep       Date:  2018-02-05       Impact factor: 3.092

5.  Management of severe hypertension in childhood Takayasu's arteritis.

Authors:  L S Milner; D W Jacobs; P D Thomson; U K Kala; J Franklin; P Beale; S E Levin
Journal:  Pediatr Nephrol       Date:  1991-01       Impact factor: 3.714

6.  Evolving strategies for the repair of complex renovascular lesions.

Authors:  K C Kent; O Salvatierra; L M Reilly; W K Ehrenfeld; J Goldstone; R J Stoney
Journal:  Ann Surg       Date:  1987-09       Impact factor: 12.969

Review 7.  Evaluation and management of bilateral renal artery stenosis in children: a case series and review.

Authors:  D Ellis; R Shapiro; V P Scantlebury; R Simmons; R Towbin
Journal:  Pediatr Nephrol       Date:  1995-06       Impact factor: 3.714

8.  Renal autotransplantation.

Authors:  A Flatmark; D Albrechtsen; G Sødal; H Bondevik; A Jakobsen; I B Brekke
Journal:  World J Surg       Date:  1989 Mar-Apr       Impact factor: 3.352

9.  Outcome following renal autotransplantation in renal artery stenosis.

Authors:  Sunil M Mhaske; Bhushan Patil; Sujata K Patwardhan; Ganesh Gopalakrishnan; Umesh Ravikant Shelke; Yash G Pamecha
Journal:  Urol Ann       Date:  2019 Jan-Mar

10.  Usefulness of Renal Autotransplantation for Radiotherapy-induced Renovascular Hypertension.

Authors:  Shinichi Wakabayashi; Hiroyuki Takaoka; Hideaki Miyauchi; Tomokazu Sazuka; Yuichi Saito; Kazumasa Sugimoto; Nobusada Funabashi; Tomohiko Ichikawa; Hisahiro Matsubara; Yoshio Kobayashi
Journal:  Intern Med       Date:  2019-02-25       Impact factor: 1.271

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.